Moreover, CP-CML early progenitors express higher levels of type I receptors, making them more responsive to the increased levels of soluble BMP2 and BMP4 in the leukaemia BM niche, resulting in expansion. This evidence concerns the gene BMP2 and chronic myelogenous leukemia, BCR-ABL1 positive.